[RGLS] QoQ Quarter Result on 30-Jun-2016 [#Q2]

Stock
[RGLS] Regulus Therapeutics Inc.
Announcement Date
02-Aug-2016
Financial Year
2016
Quarter
30-Jun-2016 [#Q2]
Profit Trend
QoQ- 0.55%
YoY- -0.26%
Quarter Report
RGLS's Result
RGLS's Financial Summary
View:
Show?
Quarter Result
31/03/17 31/12/16 30/09/16 30/06/16 31/03/16 31/12/15 30/09/15 CAGR
Revenue 18 18 204 483 489 10,860 1,865 -95.45%
PBT -20,025 -20,015 -19,515 -21,098 -21,212 -7,222 -13,016 33.23%
Tax -4 5 4 -8 -5 4 -16 -60.28%
NP -20,021 -20,020 -19,519 -21,090 -21,207 -7,226 -13,000 33.32%
Tax Rate - - - - - - - -
Total Cost 20,039 20,038 19,723 21,573 21,696 18,086 14,865 22.00%
Ratio Analysis
31/03/17 31/12/16 30/09/16 30/06/16 31/03/16 31/12/15 30/09/15 CAGR
NP Margin -111,227.78 -111,222.22 -9,568.14 -4,366.46 -4,336.81 -66.54 -697.05 2832.87%
Per Share
31/03/17 31/12/16 30/09/16 30/06/16 31/03/16 31/12/15 30/09/15 CAGR
EPS -45.34 -45.39 -44.33 -47.95 -48.28 -16.52 -30.01 31.63%
EPS Diluted -45.34 -45.39 -44.33 -47.95 -48.28 -16.52 -30.01 31.63%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.